HCQ ineffective as preventive antiviral against Covid-19: Study

New research adds to the growing body of evidence that how the famous anti-malarial drug hydroxychloroquine (HCQ) is not a possible defence against Covid-19. The study, published in the journal Annals of the Rheumatic Diseases, found that HCQ is not effective in preventing COVID-19 in patients with lupus and rheumatoid arthritis (RA), suggesting a broader interpretation of HCQ as ineffective preventive medicine for the general population.

Read the Rest at INDIA TV

Leave a Reply

Your email address will not be published. Required fields are marked *